Comparative characteristics of diabetes risk scores
https://doi.org/10.14341/DM2014317-22
Abstract
The worldwide prevalence of diabetes among adults (aged 20?79 years) was 8.35% in 2013, and this is expected to increase by 55% (592 million adults) by 2035. To avoid the increase in the prevalence of diabetes, primary prevention and early diagnosis of prediabetes are required. It is important to identify individuals at a high risk of hyperglycaemia using inexpensive and available methods. At present, risk score is an alternative to identify the risk of developing diabetes. There are approximately 10 types of risk scores in the world, and further research for the development and adaptation of risk scores for various populations are being conducted. The use of risk score methods for prediction allows the setting of the level of total risk, identification of high-risk patients and prescription of necessary preventive measures. Actual validation of existing diabetes risk score for the Russian population is being conducted. Assessment of the risk of diabetes is simple, fast, inexpensive, non-invasive and reliable.
About the Authors
Svetlana Vladimirovna Mustafina
Institute of Internal medicine and Preventive Medicine, Novosibirsk
Russian Federation
MD, PhD, Senior Research Associate, Laboratory of Population and Preventive Research for Internal Medicine and Endocrinology
Russian Federation
MD, PhD, Senior Research Associate, Laboratory of Population and Preventive Research for Internal Medicine and Endocrinology
Galina Il'inichna Simonova
Institute of Internal medicine and Preventive Medicine, Novosibirsk
Russian Federation
MD, PhD, Professor, Honorary Scientist of Russian Federation, Head of Laboratory of Population and Preventive Research for Internal Medicine and Endocrinology
Russian Federation
MD, PhD, Professor, Honorary Scientist of Russian Federation, Head of Laboratory of Population and Preventive Research for Internal Medicine and Endocrinology
Oksana Dmitrievna Rymar
Institute of Internal medicine and Preventive Medicine, Novosibirsk
Russian Federation
MD, PhD, Senior Research Associate, Laboratory of Population and Preventive Research for Internal Medicine and Endocrinology
Russian Federation
MD, PhD, Senior Research Associate, Laboratory of Population and Preventive Research for Internal Medicine and Endocrinology
References
1. Buse JB. Progressive use medical therapies in Type 2 diabetes. Diabetes spectrum. 2000; 13(4):211-228.
2. IDF Diabetes Atlas. 6-th edition. 2013. Available from: http://www.idf.org/diabetesatlas
3. Dedov II, Shestakova MV. Federal targeted programme “Prevention and Management of Socially Significant Diseases (2007-2012)”: results of the “Diabetes mellitus” sub-programme. Diabetes mellitus 2013; (2S):1-48. Available from: http://endojournals.ru/index.php/dia/article/view/3879 doi: 10.14341/2072-0351-3879
4. Сунцов ЮИ, Болотская ЛЛ, Рудакова ОГ, Андрианова ЕА, Толкачева АА, Кон ИЛ. Распространенность сахарного диабета 2 типа и его осложнений среди населения Московской области (данные одномоментных эпидемиологических исследований). Сахарный диабет. 2013;(4):6-10. [Suntsov YI, Bolotskaya LL, Rudakova OG, Andrianova EA, Tolkacheva AA, Kon IL. Prevalence of type 2 diabetes mellitus and its complications among the population of Moscow Region – a cross-sectional epidemiological study. Diabetes mellitus. 2013;(4):6-10.] doi: 10.14341/DM201346-10
5. Никитин ЮП, Симонова ГИ, Малахина ЕС, Малютина СК. Распространенность сахарного диабета у населения Сибири и Дальнего Востока. Консилиум. 1999; (6): 6-9. [Nikitin YuP, Simonova GI, Malakhina ES, Malyutina SK. Rasprostranennost' sakharnogo diabeta u naseleniya Sibiri i Dal'nego Vostoka. Konsilium. 1999; (6): 6-9.]
6. Никитин ЮП, Воевода МИ, Симонова ГИ. Сахарный диабет и метаболический синдром в Сибири и на Дальнем Востоке. Вестник Российской Академии Медицинских Наук. 2012; (1):66-74. [Nikitin YP, Voevoda МI, Simonova GI. Diabetes mellitus and metabolic syndrome in Siberia and in the Far East. Vestnik Rossiyskoy Akademii Meditsinskikh Nauk. 2012; (1):66-74.]
7. American Diabetes Association: Standards of Medical Care in Diabetes - 2013. Diabetes Care. 2013;36(Supplement 1): S11-S66. doi: 10.2337/dc13-S011
8. Lindström J, Tuomilehto J. The diabetes risk score: a practical tool to predict type 2 diabetes risk.Diabetes Care. 2003;26(3):725-731. doi: 10.2337/diacare.26.3.725
9. Saaristo T, Peltonen M, Lindström J, Saarikoski L, Sundvall J, Eriksson JG, et al. Cross-sectional evaluation of the Finnish Diabetes Risk Score: a tool to identify undetected type 2 diabetes, abnormal glucose tolerance and metabolic syndrome. Diab Vasc Dis Res. 2005;2(2):67-72. doi: 10.3132/dvdr.2005.011
10. Wang J, Stancáková A, Kuusisto J, Laakso M. Identification of undiagnosed type 2 diabetic individuals by the finnish diabetes risk score and biochemical and genetic markers: a population-based study of 7232 Finnish men. J Clin Endocrinol Metab. 2010;95(8):3858-3862. doi: 10.1210/jc.2010-0012
11. Glümer C, Carstensen B, Sandbaek A, Lauritzen T, Jørgensen T, Borch-Johnsen K. A Danish diabetes risk score for targeted screening: the Inter99 study. Diabetes Care. 2004;27(3):727-733. doi: 10.2337/diacare.27.3.727
12. Wong KC, Brown AM, Li SC. AUSDRISK - application in general practice. Aust Fam Physician. 2011;40(7):524-526.
13. Chen L, Magliano DJ, Balkau B, Colagiuri S, Zimmet PZ, Tonkin AM, et al. AUSDRISK: an Australian Type 2 Diabetes Risk Assessment Tool based on demographic, lifestyle and simple anthropometric measures. Med J Aust. 2010;192(4):197-202.
14. Schulze MB, Boeing H, Häring HU, Fritsche A, Joost HG. Validation of the German Diabetes Risk Score with metabolic risk factors for type 2 diabetes.Dtsch Med Wochenschr. 2008;133(17):878-883. doi: 10.1055/s-2008-1075664
15. Liu M, Pan C, Jin M. A Chinese diabetes risk score for screening of undiagnosed diabetes and abnormal glucose tolerance. Diabetes Technol Ther. 2011;13(5):501-507. doi: 10.1089/dia.2010.0106
16. Al-Lawati JA, Tuomilehto J. Diabetes risk score in Oman: a tool to identify prevalent type 2 diabetes among Arabs of the Middle East. Diabetes Res Clin Pract. 2007;77(3):438-444. doi: 10.1016/j.diabres.2007.01.013
17. Mohan V, Gokulakrishnan K, Ganesan A, Kumar SB. Association of Indian Diabetes Risk Score with arterial stiffness in Asian Indian nondiabetic subjects: the Chennai Urban Rural Epidemiology Study (CURES-84). J Diabetes Sci Technol. 2010;4(2):337-343. doi: 10.1177/193229681000400214
18. Mohan V, Goldhaber-Fiebert JD, Radha V, Gokulakrishnan K. Screening with OGTT alone or in combination with the Indian diabetes risk score or genotyping of TCF7L2 to detect undiagnosed type 2 diabetes in Asian Indians. Indian J Med Res. 2011;133:294-299. PMID: 21441683
19. Hippisley-Cox J, Coupland C, Robson J, Sheikh A, Brindle P. Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDScore. BMJ. 2009;338:b880. doi: 10.1136/bmj.b880
20. Collins GC,Altman DG. External validation of QDSCORE(®) for predicting the 10-year risk of developing Type 2 diabetes. Diabet Med. 2011;28(5):599-607. doi: 10.1111/j.1464-5491.2011.03237.x
21. Noble D1, Mathur R, Dent T, Meads C, Greenhalgh T. Risk models and scores for type 2 diabetes: systematic review. BMJ. 2011;343:d7163. doi: 10.1136/bmj.d7163
22. van't Riet E, Schram MT, Abbink EJ, Admiraal WM, Dijk-Schaap MW, Holleman F, et al. The Diabetes Pearl: Diabetes biobanking in The Netherlands. BMC Public Health. 2012;12:949. doi: 10.1186/1471-2458-12-949
23. Wojcik K, Gjelsvik A, Goldman D. dentifying populations at high risk for diabetes with the Behavioral Risk Factor Surveillance System, Rhode Island, 2003. Prev Chronic Dis. 2010;7(4):A86.
24. Zhang L, Zhang Z, Zhang Y, Hu G, Chen L. Evaluation of Finnish Diabetes Risk Score in screening undiagnosed diabetes and prediabetes among U.S. adults by gender and race: NHANES 1999-2010. PLoS One. 2014;9(5):e97865. doi: 10.1371/journal.pone.0097865
25. Wilson PW, Meigs JB, Sullivan L, Fox CS, Nathan DM, D'Agostino RB Sr. Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. Arch Intern Med. 2007;167(10):1068-1074. doi:10.1001/archinte.167.10.1068
26. Рекомендации: Профилактика хронических неинфекционных заболеваний. Москва; 2013. 40с. [Rekomendatsii: Profilaktika khronicheskikh neinfektsionnykh zabolevaniy. Mosсow; 2013. 40p.]
27. Мисникова ИВ, Древаль АВ, Ковалева ЮА, Губкина ВА, Лакеева ТС. Оптимизация скрининга для раннего выявления нарушений углеводного обмена. Сахарный диабет. 2014;(1):8-14. [ Misnikova IV, Dreval AV, Kovaleva YA, Gubkina VA, Lakeeva TS. Optimizing screening procedures for early detection of glycemic disorders. Diabetes mellitus. 2014;(1):8-14.] doi: 10.14341/DM201418-14
Supplementary files
Review
For citations:
Mustafina S.V., Simonova G.I., Rymar O.D. Comparative characteristics of diabetes risk scores. Diabetes mellitus. 2014;17(3):17-22. (In Russ.) https://doi.org/10.14341/DM2014317-22
Views:
2839
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
